Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methylphenidate-induced obsessive-compulsive symptoms in an elderly man.

Michael Serby1

  • 1Department of Psychiatry, Beth Israel Medical Center, and Albert Einstein College of Medicine, New York, New York 10003, USA. mserby@bethisraelny.org

CNS Spectrums
|August 9, 2003
PubMed
Summary

Methylphenidate may trigger obsessive-compulsive symptoms in elderly patients with depression and Alzheimer's disease. Symptoms resolved after switching to fluvoxamine, suggesting a drug-induced effect.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolism and Disposition of a Novel B-Cell Lymphoma-2 Inhibitor Venetoclax in Humans and Characterization of Its Unusual Metabolites.

Drug metabolism and disposition: the biological fate of chemicals·2016
Same author

Metabolism and Disposition of Hepatitis C Polymerase Inhibitor Dasabuvir in Humans.

Drug metabolism and disposition: the biological fate of chemicals·2016
Same author

Metabolism and Disposition of the Hepatitis C Protease Inhibitor Paritaprevir in Humans.

Drug metabolism and disposition: the biological fate of chemicals·2016
Same author

Metabolism and Disposition of Pan-Genotypic Inhibitor of Hepatitis C Virus NS5A Ombitasvir in Humans.

Drug metabolism and disposition: the biological fate of chemicals·2016
Same author

A 10-item smell identification scale related to risk for Alzheimer's disease.

Annals of neurology·2005
Same author

Dementia with Lewy bodies, visual hallucinations, and medications.

The American journal of psychiatry·2005

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Investigating the neuropsychiatric effects of stimulant medication in elderly patients with comorbid conditions.
  • Examining the potential for drug-induced behavioral changes in individuals with early Alzheimer's disease and treatment-resistant depression.

Observation:

  • An 82-year-old male patient with treatment-resistant depression and early Alzheimer's disease was initiated on methylphenidate.
  • The patient developed significant obsessive-compulsive behaviors following methylphenidate initiation.

Findings:

  • Obsessive-compulsive symptoms markedly improved upon discontinuation of methylphenidate and initiation of fluvoxamine.
  • The patient had no prior history of psychiatric conditions, though a family history of obsessive-compulsive disorder was noted.

Related Experiment Videos

Implications:

  • Methylphenidate may precipitate obsessive-compulsive behaviors in vulnerable elderly patients, particularly those with underlying cognitive or mood disorders.
  • This case highlights the importance of careful monitoring for emergent psychiatric symptoms during stimulant therapy in geriatric populations.
  • Fluvoxamine may be an effective treatment for methylphenidate-induced obsessive-compulsive behaviors.